Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00972
|
|||||
| Drug Name |
Clindamycin
|
|||||
| Synonyms |
7(S)-Chloro-7-deoxylincomycin; 7-CDL; 7-Chloro-7-deoxylincomycin; 7-Chlorolincomycin; 7-Deoxy-7(S)-chlorolincomycin; Antirobe; CLDM; CLINDA & IL-12; CLY; Chlolincocin; Chlorlincocin; Chlorodeoxylincomycin; Chlorolincomycin; Cleocin; Cleocin (TN); Cleocin HCl; Cleocin T Gel; Cleocin T Lotion; Cleocin T Topical Solution; ClindaDerm; Clindacin (TN); Clindamicina; Clindamicina [INN-Spanish]; Clindamycin & Interleukin 12; Clindamycin & VRC3375; Clindamycin (USAN/INN); Clindamycin [USAN:BAN:INN]; Clindamycine; Clindamycine [French]; Clindamycine [INN-French]; Clindamycinum; Clindamycinum [INN-Latin]; Clinimycin; Dalacin (TN); Dalacin C; Dalacin C Flavored Granules; Dalacin C Phosphate; Dalacin T Topical Solution; Dalacine; Evoclin (TN); Klimicin; Klindan 300; ResiDerm A; Sobelin; U 21251; U-21,251; U-21251; Zindaclin
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antibiotics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C18H33ClN2O5S
|
|||||
| Canonical SMILES |
CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl
|
|||||
| InChI |
InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9?,10-,11+,12?,13+,14-,15-,16?,18-/m1/s1
|
|||||
| InChIKey |
KDLRVYVGXIQJDK-IEEJUIGKSA-N
|
|||||
| CAS Number |
CAS 18323-44-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 425 | Topological Polar Surface Area | 128 | ||
| Heavy Atom Count | 27 | Rotatable Bond Count | 7 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
2.2
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:3745
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.